In relation to the effects of preventing phagocytosis, we also noted that induction of IL-1β under these conditions was independent of NADPH oxidase activity and most likely ROS production, since CYTD treatment fully restored the ability of mDC from CGD patients to produce IL-1β. Here, FMO5 is linked to chronic granulomatous disease.